1
H NMR spectra were recorded at 400 or 500 MHz. . LRMS and HRMS spectra were recorded at the Purdue University Department of Chemistry Mass Spectrometry Center.
S-2 tert-Butyldimethyl(2-((2S,5S,6S)-5-methyl-4-((triethylsilyl)oxy)-6-((trimethylsilyl)ethynyl)-

5,6-dihydro-2H-pyran-2-yl)ethoxy)silane (10):
A mixture of the enol ether 6 (535 mg, 1.5 mmol), aldehyde 7 (757 mg, 6.0 mmol), Jacobsen's catalyst 9 (36.5 mg, 0.07 mmol) and Molecular Sieves (4Å, 300 mg) was stirred at 23 °C under argon for 8 h. It was diluted with ethyl acetate, filtered through a short pad of Celite and washed with ethyl acetate. The filtrate was concentrated and the residue was purified by column chromatography (Hexane/EtOAc, 40:1) to give the product 10 (678 mg, 94%) as colorless oil.
[α] D
23
-13.8 (c 0.64, EtOAc). .1, 5.6 Hz, 1H), 2.08−2.02 (m, 1H), 1.80−1.64 (m, 2H), 1.22 (d, J = 6.9 Hz, 3H), 0.98 (t, J = 7.9 Hz, 9H), 0.89 (s, 9H), 0.68 (q, J = 7.9 Hz, 6H), 0.18 (s, 9H), 0.055 (s, 3H), 0.052 (s, 3H).
IR (film)

13
C NMR (100 MHz, CDCl 3 ) δ 152. 7, 103.7, 102.9, 91.0, 71.7, 68.9, 59.4, 39.1, 38.4, 25.9, 18.3, 13.5, 6.6, 4.9, -0.24, -5.4 .
(2S,3S,6S)-6-(2-((tert-Butyldimethylsilyl)oxy)ethyl)-3-methyl-2-((trimethylsilyl)ethynyl) tetrahydro-4H-pyran-4-one (5):
To a solution of 10 (639 mg, 1.32 mmol) in THF (5 mL) were added AcOH (0.3 mL, 5.29 mmol) and TBAF (1 M in THF, 2.65 mL, 2.65 mmol) at 0 o C. After being stirred at 0 o C for 2 h, more of TBAF (1 M in THF, 1.0 mL, 1 mmol) was added and the reaction was continued to stir for 1 more h. It was quenched with aq. NaHCO 3 , and extracted with ethyl acetate. The S-3 combined organic phase was washed with water, brine, dried (Na 2 SO 4 ) and concentrated. The residue was purified by column chromatography (hexane/EtOAc, 20:1) to give 5 (413 mg, 85%).
[α] D 23 -7.8 (c 1.0, EtOAc).
IR (film)  max /cm -1 2957, 2859, 2186, 1722, 1334, 1252, 1097, 843, 776 4, 100.5, 92.4, 74.0, 70.6, 58.6, 49.0, 43.9, 38.9, 25.8, 18.2, 12.3, -0.35, -5.50, -5.56 .
Assay of enantiomeric excess: Chiral HPLC analysis (chiralcel OD, 100% hexane, 1mL/min, 190 nm, t R (major) = 3.19 min., t R (minor) = 4.58 min.) 94% ee.
(2S,3R,6S)-6-(2-((tert-Butyldimethylsilyl)oxy)ethyl)-2-ethynyl-3-methyltetrahydro-4H-pyran-4-one (11):
To a solution of the starting material 5 (221 mg, 0.6 mmol) in toluene (4 mL) was added DBU (0.2 mL) and EtOH (0.1 mL). After being stirred for 24 h at 80 o C under argon, it was cooled and concentrated. The residue was purified by column chromatography (hexane/EtOAc, 20:1) to give product 11 (101 mg). The recovered starting material (25 mg) and reaction mixture (23 mg) was treated again using DBU (0.1 mL) and EtOH (0.05 mL) in toluene (2 mL) for 24 h at 80 o C under argon. It was cooled and concentrated. The residue was purified by column chromatography (hexane/EtOAc, 20:1) to give additional product (32 mg). Product 11 (133 mg) was obtained in 75% yield.
[α] D 23 -4.6 (c 0.22, EtOAc).
IR (film)  max /cm -1 3313, 2956, 2930, 2859, 2126, 1721, 1340, 1256, 1101, 837, 777 206.3, 80.7, 74.4, 73.0, 58.5, 50.2, 47.8, 39.0, 25.8, 18.2, 9.4, -5.5 .
(2S,3S,4R,6S)-6-(2-((tert-Butyldimethylsilyl)oxy)ethyl)-2-ethynyl-3-methyltetrahydro-2H-pyran-4-ol (11):
To a solution of the ketone 11 (34 mg, 0.11 mmol) in EtOH (1 mL) was added NaBH 4 (13 mg, 0.34 mmol) at 0 o C. After being stirred for 1 hour at 0 o C, it was quenched with aq. NH 4 Cl and extracted with EtOAc. The combined organic phase was washed with water, brine, dried (Na 2 SO 4 ) and concentrated. The residue was purified by column chromatography (hexane/EtOAc, 4:1) to give the alcohol 12 (28 mg, 82% ) as colorless oil. 
13
C NMR (100 MHz, CDCl 3 ) δ 81. 5, 73.3, 73.1, 72.8, 71.9, 59.0, 44.4, 40.7, 38.7, 25.8, 18.2, 13.3, -5.5 . h, ether (2 mL) was added and it was carefully neutralized with NaHCO 3 powder under ice cooling. Then aq. NaHCO 3 was added, and it was extracted with EtOAc. The combined organic phase was dried (Na 2 SO 4 ) and concentrated. The crude product was used for the next reaction directly.
1-((2S
To a solution of the above crude product and imidazole (20.4 mg, 0.3 mmol) 207.5, 87.0, 74.0, 72.0, 59.1, 41.5, 40.4, 38.8, 25.8, 25.7, 25.3, 18.3, 17.9, 12.6, -4 .1, -4.8, -5.5.
1-((2S,3R,4R,6S)-4-((tert-Butyldimethylsilyl)oxy)-6-(2-hydroxyethyl)-3-methyltetrahydro-2H-pyran-2-yl)ethanone:
To a solution of the ketone 13 (101 mg, 0.23 mmol) in DCM/MeOH (1 mL/1 mL) was added CSA (5.4 mg, 0.02 mmol) at 0 o C. After being stirred at 0 o C for 2 h, it was quenched with Et 3 N and concentrated. The residue was purified column chromatography (hexane/EtOAc, 2:1) to give the alcohol (62 mg, 80%) as colorless oil. 3425, 2956, 2931, 2858, 1717, 1254, 1082, 838, 776, 668 . 9, 87.2, 74.6, 73.6, 60.2, 41.3, 40.3, 38.0, 25.7, 25.3, 17.9, 12.5, -4 .1, -4.8.
Methyl 2-((2R,4R,5R,6S)-6-acetyl-4-((tert-butyldimethylsilyl)oxy)-5-methyltetrahydro-2H-pyran-2-yl)acetate (14):
To the mixture of the alcohol (62 mg, 0.2 mmol) and PhI(OAc) 2 (174 mg, 0.53 mmol) in DCM (2 mL) and water (0.2 mL) was added TEMPO (6.2 mg, 0.04 mmol). After being stirred at 23 o C for 4 h, it was quenched with aq. Na 2 SO 3 , and extracted with EtOAc. The combined organic phase was washed with brine, dried (Na 2 SO 4 ) and concentrated. The residue was purified by column chromatography (DCM/MeOH, 30:1) to give the acid. It was dissolved in anhydrous DCM (1 mL), and DCC (49 mg, 0.23 mmol) and DMAP (4.8 mg, 0.04 mmol) were added, followed by the addition of anhydrous MeOH (8.7 L, 0.22 mmol). After being stirred at 23 o C for 2 h, it was concentrated. The residue was purified column chromatography (hexane/EtOAc, 15:1) to give 14 (52 mg, 77% in 2 steps) as colorless oil. 9, 171.1, 86.9, 73.6, 72.0, 51.6, 40.8, 40.1, 36.5, 25.7, 25.4, 17.9, 12.5, -4 .2, -4.8.
Methyl 2-((2R,4R,5R,6S)-4-((tert-butyldimethylsilyl)oxy)-6-((E)-1-iodoprop-1-en-2-yl)-5-methyltetrahydro-2H-pyran-2-yl)acetate (15):
S-7
To a mixture of CrCl 2 (293 mg, 2.38 mmol) in THF (2 mL) was added the solution of the ketone 14 (82 mg, 0.24 mmol) and CHI 3 (281 mg, 0.71 mmol) in THF (2 mL). After being stirred at 23 o C under argon for 15 h, it was quenched with water and extracted with EtOAc. The combined organic phase was washed with water, brine, dried (Na 2 SO 4 ) and concentrated. The residue was purified column chromatography (hexane/EtOAc, 30:1) to give recovered starting material (33 mg, 40%) and the product 15 (33 mg, 50% based on 60% conversion) as colorless oil.
[α] D 23 -9.5 (c 0.42, EtOAc). 2955, 2929, 2858, 1744, 1254, 1056, 836, 668 . 3, 146.3, 86.5, 80.7, 73.7, 71.7, 51.6, 41.1, 41.0, 40.7, 25.7, 19.2, 17.9, 13.3, -4 .2, -4.8.
Methyl 2-((2R,4R,5R,6S)-4-((tert-butyldimethylsilyl)oxy)-6-((2E,4E,6S,8E,10S,11R,12R)-12-((tert-butyldimethylsilyl)oxy)-11-methoxy-6,8,10-trimethyltrideca-2,4,8-trien-2-yl)-5-methyltetrahydro-2H-pyran-2-yl)acetate (20):
A mixture of the vinyl iodide 15 (32 mg, 0.07 mmol), boronate 4 (35 mg, 0.07 mmol), Pd(PPh 3 ) 4 (4 mg) and Cs 2 CO 3 (445 mg, 1.36 mmol) in THF (2 mL) was stirred at 55 o C under argon for 2.5 h. The reaction was cooled, quenched with water, and extracted with ether. The combined organic phase was washed with water, brine, dried (Na 2 SO 4 ) and concentrated. The residue was purified column chromatography (hexane/EtOAc, 30:1) to give 20 (38 mg, 82%) as colorless oil.
[α] D 23 -9.8 (c 0.5, EtOAc). 5, 140.8, 133.3, 131.4, 130.8, 128.9, 123.7, 89.7, 88.0, 74.1, 71.5, 70.1, 60.7, 51.5, 47.4, 41.2, 40.8, 35.0, 33.6, 25.9, 25.7, 20.1, 20.0, 18.0, 17.9, 16.1, 15.4, 13.4, 11.7, -4.1, -4.7, -4.8 . 4, 140.8, 133.5, 132.9, 129.6, 129.0, 123.7, 89.6, 87.9, 73.4, 71.5, 67.8, 61.3, 51.6, 47.5, 40.8, 40.6, 40.4, 34.9, 34.7, 20.4, 19.9, 16.5, 16.2, 12.9, 11.7 .
S-9
To a solution of the alcohol (20 mg, 0.04 mmol) and VO (acac) 3, 139.7, 133.9, 128.7, 124.9, 87.9, 87.4, 73.3, 71.6, 68.2, 65.9, 61.2, 61.1, 51.5, 46.7, 40.8, 40.5, 40.4, 35.2, 35.0, 21.9, 18.9, 16.4, 12.8, 11.7, 11.6 .
2-((2R,4R,5S,6S)-4-Hydroxy-6-((S,2E,4E)-7-((2R,3R)-3-((2R,3R,4R)-4-hydroxy-3-methoxypentan-2-yl)-2-methyloxiran-2-yl)-6-methylhepta-2,4-dien-2-yl)-5-methyltetrahydro-2H-pyran-2-yl)acetic acid (1):
To a solution of the epoxide 21 (9 mg, 0.02 mmol) in MeOH (1.5 mL) and H 2 O (0.3 mL) was added K 2 CO 3 (27 mg, 0.19 mmol). After being refluxed for 2 h, it was cooled, treated with aq. NaHSO 4 (0.01 M, 50 mL) and extracted with EtOAc. The combined organic phase was washed with brine, dried (Na 2 SO 4 ) and concentrated. The residue was purified column chromatography (DCM/MeOH, 9:1) to give 1 as semi-solid (GEX1Q1) (8 mg, 92%). 126.4, 89.6, 88.5, 74.0, 73.5, 69.9, 67.8, 62.6, 61.9, 48.0, 42.3, 41.7, 41.70, 36.5, 36.4, 22.6, 19.8, 16.7, 13.5, 11.9, 11.5 Reported GEX1Q1 ( 8, 141.3, 135.3, 130.1, 126.4, 89.6, 88.5, 74.0, 73.4, 69.9, 67.8, 62.6, 61.9, 48.1, 42.0, 41.8, 41.7, 36.5, 36.4, 22.7, 19.8, 16.8, 13.5, 12.0, 11.6 
(2S,3S,4S,6S)-6-(2-((tert-Butyldimethylsilyl)oxy)ethyl)-2-ethynyl-3-methyltetrahydro-2H-pyran-4-ol (16):
To a solution of the ketone 11 (20.8 mg, 0.07 mmol) in THF (1 mL) was added L-selectride (0.18 mL, 1 M in THF, 0.18 mmol) at -78 o C. After being stirred for 1 h at the same temperature, it was quenched with aq. NH 4 Cl and extracted with EtOAc. The combined organic phase was washed with water, brine, dried (Na 2 SO 4 ) and concentrated. The residue was purified column chromatography (hexane/EtOAc, 4:1) to give the alcohol 16 (16.9 mg, 81%) as colorless oil. 
13
C NMR (100 MHz, CDCl 3 ) δ 82. 6, 73.0, 68.4, 67.9, 67.8, 59.3, 40.3, 39.3, 38.7, 25.9, 18.3, 13.4, -5.4 .
1-((2S,3R,4S,6S)-4-((tert-Butyldimethylsilyl)oxy)-6-(2-((tert-butyldimethylsilyl)oxy)ethyl)-3-methyltetrahydro-2H-pyran-2-yl)ethanone (17):
To a solution of the alkyne 16 (16 mg, 0.05 mmol) in THF (1 mL) was added the solution of HgSO 4 (3.2 mg, 0.01 mmol) in 3M H 2 SO 4 (0.5 mL) at 0 o C. After being stirred at 23 o C for 1 h, ether (2 mL) was added and it was carefully neutralized with NaHCO 3 powder under ice cooling. Then aq. NaHCO 3 was added, and it was extracted with EtOAc. The combined organic phase was dried (Na 2 SO 4 ) and concentrated for the next reaction directly.
To a solution of the above crude product and 2, 6-lutidine (37 L, 0.32 mmol) in DCM (2 mL) was added TBSOTf (49 L, 0.21 mmol) at 0 o C. After being stirred at 0 o C for 4 h, it was quenched with aq. NaHCO 3 and extracted with CH 2 Cl 2 . The combined organic phase was washed with water, brine, dried (Na 2 SO 4 ) and concentrated. The 1 H-NMR of the crude product showed the formation of a substantial amount of silyl enol ether. The crude product was employed for the selective deprotection of silyl enol ether. Thus, the crude product was dissolved in THF (1 mL) and AcOH (61 L, 1.07 mmol) was added at 0 o C, followed by the addition of TBAF (1 M in THF, 0.27 mL, 0.27 mmol). After being stirred at 0 o C for 30 min, it was quenched with aq. NaHCO 3 and extracted with EtOAc. The combined organic phase was washed with water, brine, dried (Na 2 SO 4 ) and concentrated. The residue was purified column chromatography (hexane/EtOAc, 30:1) to afford the ketone 17 (12 mg, 52% in 3 steps) as colorless oil. 9, 82.8, 69.4, 67.3, 59.2, 40.2, 39.0, 37.4, 25.9, 25.8, 25.7, 18.2, 18.0, 13.6, -4.6, -5.0, -5.5 .
Methyl 2-((2R,4S,5R,6S)-6-acetyl-4-((tert-butyldimethylsilyl)oxy)-5-methyltetrahydro-2H-pyran-2-yl)acetate (18):
To a solution of the ketone 17 (106 mg, 0.24 mmol) in DCM/MeOH (1 mL/1 mL) was added CSA (5.7 mg, 0.024 mmol) at 0 o C. After being stirred at 0 o C for 2 h, it was quenched with Et 3 N and concentrated. The residue was purified column chromatography (hexane/EtOAc, 2:1) to give the product (75 mg, 96%) as colorless oil. 70.8, 69.0, 60.9, 39.9, 37.8, 37.2, 25.8, 25.7, 18 .0, 13.5, -4.6, -5.0.
To a mixture of the alcohol (72 mg, 0.22 mmol) and PhI(OAc) 2 (198 mg, 0.61 mmol) in DCM (2 mL) and water (0.2 mL) was added TEMPO (7.1 mg, 0.04 mmol). After being stirred at 23 o C for 8 h, it was quenched with aq. Na 2 SO 3 , and extracted with EtOAc. The combined organic phase was washed with brine, dried (Na 2 SO 4 ) and concentrated for short column chromatography (DCM/MeOH, 20:1) to give the acid. It was dissolved in anhydrous DCM (2 mL), and DCC (56 mg, 0.27 mmol) and DMAP (5.5 mg, 0.04 mmol) were added, followed by the addition of anhydrous MeOH (10 L, 0.25 mmol). After being stirred at 23 o C overnight, it was concentrated. The residue was purified column chromatography (hexane/EtOAc, 15:1) to give the ester 18 (71 mg, 90% in 2 steps) as colorless oil.
[α] D 23 -1.1 (c 0.82, EtOAc).
IR (film)  max /cm -1 2955, 2929, 2857, 1744, 1717, 1254, 1060, 838, 668 3, 171.2, 82.9, 69.0, 67.8, 51.5, 40.8, 39.4, 37.0, 25.8, 25.7, 18.0, 13.5, -4.6, -5 .0.
Methyl 2-((2R,4S,5R,6S)-4-((tert-butyldimethylsilyl)oxy)-6-((E)-1-iodoprop-1-en-2-yl)-5-methyltetrahydro-2H-pyran-2-yl)acetate (19):
To a mixture of CrCl 2 (230 mg, 1.87 mmol) in THF (2 mL) was added dropwise the solution of the ketone 18 (43 mg, 0.12 mmol) and CHI 3 (196 mg, 0.5 mmol) in THF (2 mL). After being stirred at 23 o C under argon for 4 h, it was quenched with water and extracted with EtOAc. The combined organic phase was washed with water, brine, dried (Na 2 SO 4 ) and concentrated. The residue was purified column chromatography (hexane/EtOAc, 40:1) to give the vinyl iodide 19 (26 mg, 44%) as colorless oil. 3, 146.7, 82.2, 80.5, 69.2, 68.0, 51.5, 40.9, 39.6, 37.7, 25.8, 19.0, 18.0, 14.1, -4.6, -5 .0. 5, 140.5, 133.7, 131.4, 130.8, 128.6, 123.8, 89.7, 83.5, 70.0, 69.4, 67.7, 60.7, 51.4, 47.4, 41.1, 39.7, 37.3, 35.0, 33.7, 25.9, 25.8, 20.1, 20.0, 18.1, 16.1, 15.4, 14.2, 11.5, -4.6, -4.7, -5 .0. ,3R)-3-((2R,3R,4R )-4-hydroxy-3-methoxypentan-2-yl)-2-methyloxiran-2-yl)-6-methylhepta-2,4-dien-2-yl)-5-methyltetrahydro-2H-pyran-2-yl)acetic acid (23):
2-((2R,4S,5S,6S)-4-Hydroxy-6-((S,2E,4E)-7-((2R
S-15
To a solution of 22 (20 mg, 0.023 mmol) in THF (2 mL) was added pyridine (0.6 mL) and Py.HF (70% HF, 0.6 mL). After being stirred at 55-60 o C in a plastic flask for 20 h, it was cooled, quenched with aq. NaHCO 3 and extracted with EtOAc. The combined organic phase was washed with water, brine, dried (Na 2 SO 4 ) and concentrated. The residue was purified column chromatography (hexane/EtOAc, 2:1) to give the de-protected product (10 mg, 72%) as colorless oil.
[ 
13
C NMR (100 MHz, CDCl 3 ) δ 171. 5, 140.5, 133.5, 129.6, 128.7, 123.8, 89.6, 83.1, 68.9, 67.8, 67.6, 61.3, 51.5, 47.5, 40.9, 39.0, 36.4, 34.9, 34.7, 20.4, 20.0, 16.5, 16.2, 13.5, 11.5. To a solution of the triene (8 mg, 0.02 mmol) and VO(acac) 2 (0.94 mg, 0.003 mmol) in DCM (1 mL) was added To a solution of the above crude product in MeOH (1 mL) and water (0.2 mL) was added K 2 CO 3 (14.7 mg, 0.11 mmol). After being refluxed for 2 h, it was cooled, treated with aq. NaHSO 4 (0.01 M, 50 mL) and extracted with EtOAc. The combined organic phase was washed with brine, dried (Na 2 SO 4 ) and concentrated. The residue was purified by column chromatography (DCM/MeOH, 9:1) to give the acid 23 (5-epi-GEX1Q1) (4 mg, 50% in 2 steps) a semi solid.
[α] D 23 +16.9 (c 0.13, MeOH).
IR (film)  max /cm -1 3444, 2962, 2927, 1728, 1716, 1511, 1248, 1086, 1043, 737, 668 
